Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension
- DOI
- 10.1177/03331024261462833
- Published
- 2026-08
- Container
- Cephalalgia
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1177/03331024261462833,
title = {Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension},
author = {Shengyuan Yu and Hui Su and Hebo Wang and Meiyun Zhang and Steve Barash and Glenn Chen and Gloria Yiu and Juline Bryson and Yoel Kessler and Yael Carmeli Schwartz and Zipi Roth-Ben Arie and Michal Benedek-Segal and Xiaoping Ning},
year = {2026},
journal = {Cephalalgia},
doi = {10.1177/03331024261462833},
url = {https://doi.org/10.1177/03331024261462833}
}RIS
TY - JOUR TI - Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension AU - Shengyuan Yu AU - Hui Su AU - Hebo Wang AU - Meiyun Zhang AU - Steve Barash AU - Glenn Chen AU - Gloria Yiu AU - Juline Bryson AU - Yoel Kessler AU - Yael Carmeli Schwartz AU - Zipi Roth-Ben Arie AU - Michal Benedek-Segal AU - Xiaoping Ning PY - 2026 JO - Cephalalgia DO - 10.1177/03331024261462833 UR - https://doi.org/10.1177/03331024261462833 ER -
APA
Yu, S., Su, H., Wang, H., Zhang, M., Barash, S., Chen, G., Yiu, G., Bryson, J., Kessler, Y., Schwartz, Y. C., Arie, Z. R., Benedek-Segal, M., & Ning, X. (2026). Fremanezumab for the preventive treatment of migraine in Chinese adults: A Phase 3, randomized controlled trial with an open-label extension. Cephalalgia. https://doi.org/10.1177/03331024261462833
Source records
- crossref · retrieved 2026-09-25T18:13:37.183Z